** Shares of medical device company Autonomix Medical
slump 53% to $6.35 in early trading
** AMIX sold ~1.4 mln shares in a public offering at $6.54/shr for gross proceeds of $9 mln
** Offering priced at about 52% discount to stock's last close
** Company has ~1.2 mln outstanding shares for $15.6 mln market capitalization, according to data compiled by LSEG
** Ladenburg Thalmann sole bookrunning manager for the offering
** AMIX plans to use the proceeds to fund its clinical trial, among other purposes
** As of last close, AMIX shares up 170% since debut on Jan. 29 this year
(Reporting by Arasu Kannagi Basil in Bengaluru)
((ArasuKannagi.Basil@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。